Central Nervous System Clinical Research
A Leader in CNS Clinical Trials
Linical Accelovance is a leading CNS CRO (clinical research organization), with a strong legacy in central nervous system diseases and disorders. CNS diseases are unfortunately very debilitating and prevalent in today’s world, and it is because of this that Linical Accelovance is committed to advancing research into the prevention and treatment of these conditions. Our experienced and therapeutically focused project teams play an important role in advancing clients’ compounds through the drug development process. We have deep knowledge of the nuances involved in successfully conducting CNS studies, from recruiting the right patients at the right time, to ensuring consistency in completing assessments, and ensuring all stakeholders involved are aligned.
Linical Accelovance has navigated challenging neurology clinical trial designs and complex patient populations, including programs with rare, with hard to find patients. Our presence in over 20 locations across the globe makes us well-versed with finding the right patients in a timely manner. Treatment settings for neurology and psychiatry patients can vary greatly across different parts of the world, and we have strategic and proven approaches to identify and attract these patients whether they are in institutional settings, nursing homes, or living at home with family members.
For many neurological studies, there is intense competition and demand for patients. Our strong site relationships and investigator alliances mean your program will get the attention it deserves. Additionally, our relationships with industry KOLs, central labs, and imaging centers help ensure standardization of assessments such as MRIs, CT scans, PET scans, and/or EEGs. From innovative and strategic planning, to our adaptable project teams, Linical Accelovance helps you operationalize and meet your project goals of high quality data and timely study execution.
Your Trusted CRO for Neurology and Psychiatry Programs
The Linical Accelovance team has worked on numerous CNS clinical studies spanning Phase I-IV. We have experience in routes of administration and patient populations including adult, infant, pediatric, elderly, and rare populations. Our vast CNS clinical research experience means we understand the complexities of these programs and can support your trial in indications such as:
- Alzheimer's Disease
- Parkinson’s Disease
- Autoimmune Neurological Disorders (Multiple Sclerosis)
- Duchenne’s Muscular Dystrophy
- Bipolar Disorder
- Mood Disorders
- Epilepsy and Seizure Disorders
- Sleep Disorders and Narcolepsy
- Mild Cognitive Impairment
- Memory Impairment
- Addiction and Drug Dependencies
- Depression/Major Depressive Disorder
- Seizures and Spasms
- Spinal Cord Injuries
- Amyotrophic Lateral Sclerosis
- Neurodegenerative Disorders
- Movement Disorders
- Neuromuscular Disorders (Disease of Peripheral Nerve, Neuromuscular Junction and Muscle)
- Pain Syndromes
Contact Us to learn more about our central nervous system research capabilities or request a quote/consultation for an upcoming project!